Project Details
Description
A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent or Persistent Endometrial Cancer
Status | Active |
---|---|
Effective start/end date | 5/19/21 → 5/31/26 |
Funding
- ALLIANCE FOUNDATION TRIALS, LLC